Skip to main content
Clinical Trials/IRCT20180106038239N1
IRCT20180106038239N1
Recruiting
未知

The effect of cognitive and motor dual task training on improvement of balance, some kinematic parameters of gait cycle and fear of falling in people with idiopathic Parkinson’s disease

Rasht University of Medical Sciences0 sites36 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Rasht University of Medical Sciences
Enrollment
36
Status
Recruiting
Last Updated
8 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
8 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Rasht University of Medical Sciences

Eligibility Criteria

Inclusion Criteria

  • PD patients diagnosed with Hoehn and Yahr score of 2 or 3
  • Prescribed one or more anti\-parkinsonism medications by a consultant neurologist or consultant physician with specialist knowledge of neurological disorders
  • Stable medication use; that is, not altered within the previous month and not expected to change during next 3 months
  • Willing to be assigned to any of the three interventions
  • Able to walk 100 m independently with or without gait aids;
  • Able to do simple orders and getting a score more than 24 on the Mini\-Mental Status Examination (MMSE)
  • Age between 50\-75
  • Getting a score less than 14 in Beck Depression Inventory

Exclusion Criteria

  • Any clinical condition that make it impossible to use physical effort
  • Patients with cardiovascular and pulmonary diseases
  • Significant physical limitations
  • Sensory system pathology affecting walking (e.g. blindness, deafness).
  • To have a surgery for PD such as deep brain stimulation
  • Suspected Parkinsonism due to causes other than idiopathic PD.
  • Current participation in any other behavioral or exercise programs.
  • Participation of a structured exercise program in the preceding 2 months.
  • Unavailability during the period of the study.
  • Patients with dementia or significant cognitive impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials